Marta Barisella, MD (she/her/hers)

Pathologist
Department of Pathology,Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy, Italy

Doctor of Medicine and Surgery (110/110 cum laude) at University of Milan, Milan, Italy (1995-2001);
Postgraduate in Anatomic Pathology (70/70) at University of Padua, Padua, Italy (2001-2006);
Fellowship with prof Juan Rosai at IRCCS - National Cancer Institute of Milan 20133 Milan – Italy (2000-2005);
Fellowship at IRCCS - National Cancer Institute of Milan - Via Venezian, 1 – 20133 Milan – Italy (2005-2007);
Assistant role at managerial, level I. Routine and research work in oncologic surgical pathology mainly soft tissue and skin pathology at IRCCS - National Cancer Institute of Milan - Via Venezian, 1 – 20133 Milan - Italy (from 2007 up to now).

Poster(s):

• (P 272) A COMPARATIVE ASSESSMENT OF SELINEXOR WITH TRABECTEDIN OR LURBINECTEDIN IN PATIENT-DERIVED XENOGRAFTS (PDX) OF DEDIFFERENTIATED LIPOSARCOMA (DDLPS)

• (P 273) COMPARISON OF A PATIENT-DERIVED XENOGRAFTS (PDX) OF MYXOID PLEOMORPHIC LIPOSARCOMA (MPL) AND PLEOMORPHIC LIPOSARCOMA (PL) HIGHLIGHTS THE EFFECTIVENESS OF ERIBULIN IN A PDX OF MPL

• (P 378) MULTIOMICS PROFILING OF EPITHELIOID SARCOMA UNVEILS EPIGENETIC CIRCUITRIES THAT UNDERLIE THE PATHOBIOLOGY OF PROXIMAL AND CLASSIC SUBTYPES: RESULTS FROM THE ISG EPISOBS OBSERVATIONAL STUDY